| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.16 | 0.4 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.04 | 0.4 |